Cargando…

Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder

OBJECTIVE: A recent 3-month double-blind, placebo-controlled study demonstrated efficacy and safety of pediatric prolonged-release melatonin (PedPRM) for insomnia in children with autism spectrum disorder. This study examined the long-term effects of PedPRM treatment on sleep, growth, body mass inde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malow, Beth A., Findling, Robert L., Schroder, Carmen M., Maras, Athanasios, Breddy, John, Nir, Tali, Zisapel, Nava, Gringras, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084705/ https://www.ncbi.nlm.nih.gov/pubmed/31982581 http://dx.doi.org/10.1016/j.jaac.2019.12.007

Ejemplares similares

Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder
por: Maras, Athanasios, et al.
Publicado: (2018)

Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life
por: Schroder, Carmen M., et al.
Publicado: (2019)

Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial
por: Roth, Thomas, et al.
Publicado: (2015)

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal
por: Lemoine, Patrick, et al.
Publicado: (2011)

Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials
por: Lemoine, Patrick, et al.
Publicado: (2012)

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
por: Wade, Alan G, et al.
Publicado: (2010)

Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin
por: Hajak, Göran, et al.
Publicado: (2015)

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
por: Wade, Alan G, et al.
Publicado: (2014)

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study
por: Garfinkel, Doron, et al.
Publicado: (2011)

New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
por: Zisapel, Nava
Publicado: (2018)

Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder
por: Lalanne, Sébastien, et al.
Publicado: (2021)

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials
por: Grossman, Ehud, et al.
Publicado: (2011)

Prolonged–release melatonin in patients with idiopathic REM sleep behavior disorder
por: Jun, Jin‐Sun, et al.
Publicado: (2019)

Prolonged–release melatonin in patients with idiopathic REM sleep behavior disorder
Publicado: (2019)

Melatonin and Comorbidities in Children with Autism Spectrum Disorder
por: Gagnon, Katia, et al.
Publicado: (2018)

An Automated Functional Annotation Pipeline That Rapidly Prioritizes Clinically Relevant Genes for Autism Spectrum Disorder
por: Veatch, Olivia J., et al.
Publicado: (2020)

Bioavailability of Oniria(®), a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
por: Román Martinez, Manuel, et al.
Publicado: (2022)

Heritability of the melatonin synthesis variability in autism spectrum disorders
por: Benabou, Marion, et al.
Publicado: (2017)

Central Precocious Puberty (CPP) in Two Girls With Autism Spectrum Disorder (ASD)
por: Moriuchi, Yuko, et al.
Publicado: (2023)

Effect of melatonin on the onset of puberty in male juvenile rats
por: Venugopal, Satya Prasad
Publicado: (2019)

Melatonin Rhythm and Its Relation to Sleep and Circadian Parameters in Children and Adolescents With Autism Spectrum Disorder
por: Martinez-Cayuelas, Elena, et al.
Publicado: (2022)

Patterns of Joint Improvisation in Adults with Autism Spectrum Disorder
por: Brezis, Rachel-Shlomit, et al.
Publicado: (2017)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Mutation screening of melatonin-related genes in patients with autism spectrum disorders
por: Jonsson, Lina, et al.
Publicado: (2010)

The Relationship between Autism Spectrum Disorder and Melatonin during Fetal Development
por: Jin, Yunho, et al.
Publicado: (2018)

Adherence to treatment and parents’ perspective about effectiveness of melatonin in children with autism spectrum disorder and sleep disturbances
por: Sadeh, Hadar, et al.
Publicado: (2023)

PT655. The effectiveness of prolonged-release melatonin among primary insomnia patients whose sleep schedule was set
por: Park, Boram, et al.
Publicado: (2016)

Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents
por: Stepanova, Ekaterina, et al.
Publicado: (2017)

Melatonin ameliorates sleep–wake disturbances and autism‐like behaviors in the Ctnnd2 knock out mouse model of autism spectrum disorders
por: Xu, Man, et al.
Publicado: (2023)

Advances in the Research of Melatonin in Autism Spectrum Disorders: Literature Review and New Perspectives
por: Tordjman, Sylvie, et al.
Publicado: (2013)

The serotonin-N-acetylserotonin–melatonin pathway as a biomarker for autism spectrum disorders
por: Pagan, C, et al.
Publicado: (2014)

Efficacy of Melatonin for Insomnia in Children with Autism Spectrum Disorder: A Meta-analysis
por: Xiong, Mei, et al.
Publicado: (2023)

Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin
por: Chua, Hui Ming, et al.
Publicado: (2016)

Melatonin Administration Accelerates Puberty Onset in Mice by Promoting FSH Synthesis
por: Yang, Chan, et al.
Publicado: (2021)

The physical and psychiatric health conditions related to autism genetic scores, across genetic ancestries, sexes and age-groups in electronic health records
por: Niarchou, Maria, et al.
Publicado: (2023)

Mock Juror Perceptions of Child Witnesses on the Autism Spectrum: The Impact of Providing Diagnostic Labels and Information About Autism
por: Crane, Laura, et al.
Publicado: (2018)

Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
por: Ait Abdellah, Samira, et al.
Publicado: (2023)

Study protocol: a randomized controlled trial investigating the effects of a psychosexual training program for adolescents with autism spectrum disorder
por: Visser, Kirsten, et al.
Publicado: (2015)

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
por: Hardeland, Rüdiger
Publicado: (2009)

Transient central precocious puberty: a new entity among the spectrum of precocious puberty?
por: Assirelli, Valentina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8tkh2obdsuue7jol3upembs0r